A 3-day-old term Indian male infant born to an O-positive mother (A-positive blood group) presents with jaundice. The infant's serum bilirubin is 18 mg/dL. Regarding management and phototherapy criteria, all of the following are correct EXCEPT:

Explanation

## Management of Neonatal Jaundice: Phototherapy and Exchange Transfusion ### Why Option 2 is INCORRECT (The Answer) **Key Point:** IVIG is **NOT contraindicated in ABO incompatibility**. In fact, IVIG is indicated in both **Rh incompatibility AND ABO incompatibility** when hemolytic disease is present. IVIG reduces hemolysis by blocking Fc receptors on macrophages, preventing RBC destruction. **High-Yield:** IVIG is used in hemolytic disease of the newborn (HDN) regardless of the blood group incompatibility — it is a key adjunctive therapy alongside phototherapy and exchange transfusion. ### Why the Other Options are CORRECT #### Option 0: Phototherapy Threshold at 72 Hours ```mermaid flowchart TD A[Term infant at 72 hours]:::outcome A --> B{Serum bilirubin level?}:::decision B -->|< 17.5 mg/dL| C[Observe, monitor]:::action B -->|17.5-25 mg/dL| D[Initiate phototherapy]:::action B -->|> 25 mg/dL| E[Exchange transfusion + phototherapy]:::urgent ``` **Clinical Pearl:** At 72 hours (3 days), a term infant with bilirubin of 18 mg/dL exceeds the phototherapy threshold (~17.5 mg/dL) and requires immediate phototherapy initiation. #### Option 1: Exchange Transfusion Threshold **Key Point:** Exchange transfusion is indicated when bilirubin exceeds the exchange transfusion threshold. For a **term infant at 72 hours**, the threshold is approximately **25 mg/dL**. This infant at 18 mg/dL does not yet meet this criterion but is approaching it. #### Option 3: Intensive Phototherapy Efficacy | Phototherapy Type | Spectrum | Efficacy | Notes | |---|---|---|---| | **Conventional (fluorescent)** | Broad spectrum | Baseline | Older technology | | **LED (blue-spectrum)** | 460–490 nm (peak absorption by bilirubin) | ↑ 2–3 fold | Preferred; more effective, less heat | | **Intensive phototherapy** | Blue LED, multiple units | Maximum | Used for high-risk infants | **High-Yield:** LED phototherapy is more effective than conventional fluorescent phototherapy and is now the standard of care in most neonatal units. ### Management Summary for This Case 1. **Phototherapy:** Initiate immediately (bilirubin 18 mg/dL at 72 hours exceeds threshold) 2. **IVIG:** Consider if hemolytic disease confirmed (ABO incompatibility is hemolytic) 3. **Monitor:** Repeat bilirubin in 4–6 hours; if rising rapidly, prepare for exchange transfusion 4. **Feeding:** Optimize breastfeeding or formula feeding to reduce enterohepatic circulation **Mnemonic for Phototherapy Indications — **LIGHT**: - **L**evel of bilirubin (check nomogram) - **I**ntensity of phototherapy (conventional vs. intensive) - **G**estational age (lower thresholds for preterm) - **H**emolytic disease (lower thresholds) - **T**ime of life (thresholds increase with postnatal age) [cite:Park 26e Ch 8, Harrison 21e Ch 173]